• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长新冠后遗症:已知和未知:最新信息综述。

Sequelae of long COVID, known and unknown: A review of updated information.

机构信息

Institute of Neurology, National Clinical Research Center for Infectious Diseases, the Third People's Hospital of Shenzhen, Shenzhen, China.

Department of Hepatology, National Clinical Research Center for Infectious Diseases, the Third People's Hospital of Shenzhen, Shenzhen, China.

出版信息

Biosci Trends. 2023 May 15;17(2):85-116. doi: 10.5582/bst.2023.01039. Epub 2023 Mar 14.

DOI:10.5582/bst.2023.01039
PMID:36928222
Abstract

Over three years have passed since the COVID-19 pandemic started. The dangerousness and impact of COVID-19 should definitely not be ignored or underestimated. Other than the symptoms of acute infection, the long-term symptoms associated with SARS-CoV-2 infection, which are referred to here as "sequelae of long COVID (LC)", are also a conspicuous global public health concern. Although such sequelae were well-documented, the understanding of and insights regarding LC-related sequelae remain inadequate due to the limitations of previous studies (the follow-up, methodological flaws, heterogeneity among studies, etc.). Notably, robust evidence regarding diagnosis and treatment of certain LC sequelae remain insufficient and has been a stumbling block to better management of these patients. This awkward situation motivated us to conduct this review. Here, we comprehensively reviewed the updated information, particularly focusing on clinical issues. We attempt to provide the latest information regarding LC-related sequelae by systematically reviewing the involvement of main organ systems. We also propose paths for future exploration based on available knowledge and the authors' clinical experience. We believe that these take-home messages will be helpful to gain insights into LC and ultimately benefit clinical practice in treating LC-related sequelae.

摘要

自 COVID-19 大流行开始以来,已经过去了三年。COVID-19 的危险性和影响绝对不容忽视或低估。除了急性感染的症状外,与 SARS-CoV-2 感染相关的长期症状,也被称为“长新冠后遗症 (LC)”,也是一个引人关注的全球公共卫生问题。尽管这些后遗症已经有详细的记录,但由于之前研究的局限性(随访、方法学缺陷、研究之间的异质性等),对 LC 相关后遗症的认识和见解仍然不足。值得注意的是,某些 LC 后遗症的诊断和治疗的有力证据仍然不足,这是更好地管理这些患者的绊脚石。这种尴尬的局面促使我们进行了这项研究。在这里,我们全面回顾了最新信息,特别是侧重于临床问题。我们试图通过系统地回顾主要器官系统的受累情况,提供与 LC 相关后遗症的最新信息。我们还根据现有知识和作者的临床经验,提出了未来探索的途径。我们相信,这些要点将有助于深入了解 LC,并最终有益于治疗 LC 相关后遗症的临床实践。

相似文献

1
Sequelae of long COVID, known and unknown: A review of updated information.长新冠后遗症:已知和未知:最新信息综述。
Biosci Trends. 2023 May 15;17(2):85-116. doi: 10.5582/bst.2023.01039. Epub 2023 Mar 14.
2
Return-to-work, disabilities and occupational health in the age of COVID-19.新冠疫情时代的重返工作岗位、残疾与职业健康。
Scand J Work Environ Health. 2021 Jul 1;47(5):408-409. doi: 10.5271/sjweh.3960. Epub 2021 May 18.
3
Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.监测纽约市初级保健患者感染 COVID-19 后的新症状。
J Am Board Fam Med. 2021 Sep-Oct;34(5):1014-1016. doi: 10.3122/jabfm.2021.05.210122.
4
An overview of post COVID sequelae.新冠后遗症概述。
J Basic Clin Physiol Pharmacol. 2022 Apr 15;33(6):715-726. doi: 10.1515/jbcpp-2022-0057. eCollection 2022 Nov 1.
5
Long COVID and its Management.长新冠及其管理。
Int J Biol Sci. 2022 Jul 11;18(12):4768-4780. doi: 10.7150/ijbs.75056. eCollection 2022.
6
Systems analysis of innate and adaptive immunity in Long COVID.长新冠患者固有免疫和适应性免疫的系统分析。
Semin Immunol. 2024 Mar;72:101873. doi: 10.1016/j.smim.2024.101873. Epub 2024 Mar 8.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Cellular and molecular biomarkers of long COVID: a scoping review.长新冠的细胞和分子生物标志物:范围综述。
EBioMedicine. 2023 May;91:104552. doi: 10.1016/j.ebiom.2023.104552. Epub 2023 Apr 8.
9
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.急性新冠病毒感染后疾病的流行病学和器官特异性后遗症:叙述性综述。
J Infect. 2021 Jul;83(1):1-16. doi: 10.1016/j.jinf.2021.05.004. Epub 2021 May 14.
10
Clinical trials on the pharmacological treatment of long COVID: A systematic review.长新冠的药物治疗临床试验:系统评价。
J Med Virol. 2023 Jan;95(1):e28289. doi: 10.1002/jmv.28289. Epub 2022 Nov 18.

引用本文的文献

1
Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants.新冠长期症状的事实与发现:对74075名中国参与者的大规模在线调查
Lancet Reg Health West Pac. 2024 Oct 11;52:101218. doi: 10.1016/j.lanwpc.2024.101218. eCollection 2024 Nov.
2
Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.新型口服小分子RdRp抑制剂SHEN26治疗新型冠状病毒肺炎的疗效和安全性:一项多中心、随机、双盲、安慰剂对照的II期临床试验
Virol J. 2025 Jan 25;22(1):16. doi: 10.1186/s12985-025-02631-y.
3
Piecing together the narrative of #longcovid: an unsupervised deep learning of 1,354,889 X (formerly Twitter) posts from 2020 to 2023.
拼凑“长新冠”的故事:对2020年至2023年1354889条X(原推特)帖子进行无监督深度学习
Front Public Health. 2024 Dec 16;12:1491087. doi: 10.3389/fpubh.2024.1491087. eCollection 2024.
4
Effectiveness of an online multimodal rehabilitation program in long COVID patients: a randomized clinical trial.在线多模式康复计划对新冠长期症状患者的有效性:一项随机临床试验。
Arch Public Health. 2024 Sep 18;82(1):159. doi: 10.1186/s13690-024-01354-w.
5
Proposal to apply a "Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment (PERMA)" based approach to manage the COVID-19-related mental health problems in the era of long COVID.关于应用基于“积极情绪、投入、人际关系、意义和成就(PERMA)”的方法来管理长期新冠疫情时代与新冠病毒相关心理健康问题的提议。
Glob Health Med. 2024 Apr 30;6(2):160-163. doi: 10.35772/ghm.2023.01102.
6
Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study.奥密克戎变异株感染 COVID-19 患者出院后 3 个月长新冠影响因素分析:一项横断面研究。
BMC Infect Dis. 2024 Jan 2;24(1):36. doi: 10.1186/s12879-023-08947-w.